Tag: Stock
Among people with eczema open to a new medicine, 94% wanted a test to help choose treatment. – Stock Titan
eczemarelief
September 24, 2026
This biopharma stock could more than double on oral eczema treatment, Goldman Sachs says – CNBC
eczemarelief
April 17, 2026
Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus – ts2.tech
eczemarelief
December 28, 2025
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September – The Globe and Mail
eczemarelief
October 5, 2025